Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4270
-0.0054 (-1.25%)
Jun 20, 2025, 11:32 AM - Market open
Impact BioMedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 1.32 | 2 | 0 | 0 | 0.05 | 0.07 | Upgrade
|
| Cash & Short-Term Investments | 1.32 | 2 | 0 | 0 | 0.05 | 0.07 | Upgrade
|
| Cash Growth | 65800.00% | 199800.00% | -50.00% | -95.65% | -36.42% | -33.46% | Upgrade
|
| Other Receivables | 0 | - | 0.13 | - | - | - | Upgrade
|
| Receivables | 0.2 | 0.18 | 0.33 | 0.02 | 0.2 | - | Upgrade
|
| Prepaid Expenses | 0.17 | 0.27 | - | 0.06 | 0 | - | Upgrade
|
| Other Current Assets | - | - | - | 0.04 | 0.04 | 0.04 | Upgrade
|
| Total Current Assets | 2.18 | 2.45 | 0.33 | 0.12 | 0.29 | 0.11 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.02 | 0.29 | 0.28 | - | - | Upgrade
|
| Long-Term Investments | - | - | - | 0.78 | 4.82 | 0.63 | Upgrade
|
| Goodwill | - | - | 25.09 | 25.09 | 25.09 | 25.09 | Upgrade
|
| Other Intangible Assets | 17.85 | 17.81 | 18.92 | 20.03 | 21.15 | 22.26 | Upgrade
|
| Total Assets | 20.05 | 20.29 | 44.63 | 46.5 | 56.43 | 48.09 | Upgrade
|
| Accounts Payable | 0.62 | 0.71 | 0.83 | 0.54 | 0.12 | 0.01 | Upgrade
|
| Accrued Expenses | 0.22 | 0.19 | 0.23 | 0.06 | 0.01 | 0 | Upgrade
|
| Short-Term Debt | 9.14 | 8.84 | 12.07 | 9.99 | 12.52 | 1.06 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.04 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 9.97 | 9.79 | 13.14 | 10.59 | 12.65 | 1.07 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.27 | 3.27 | 3.24 | 3.24 | 3.86 | 5.25 | Upgrade
|
| Total Liabilities | 13.24 | 13.05 | 16.37 | 13.83 | 16.5 | 6.32 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.07 | 0.13 | 0.13 | Upgrade
|
| Additional Paid-In Capital | 42.71 | 41.86 | 38.11 | 38.11 | 38.06 | 38.06 | Upgrade
|
| Retained Earnings | -38.94 | -37.67 | -12.96 | -8.63 | -1.57 | -0.27 | Upgrade
|
| Total Common Equity | 3.78 | 4.2 | 25.16 | 29.56 | 36.61 | 37.91 | Upgrade
|
| Minority Interest | 2.97 | 2.98 | 3.04 | 3.11 | 3.32 | 3.86 | Upgrade
|
| Shareholders' Equity | 6.81 | 7.24 | 28.26 | 32.67 | 39.92 | 41.77 | Upgrade
|
| Total Liabilities & Equity | 20.05 | 20.29 | 44.63 | 46.5 | 56.43 | 48.09 | Upgrade
|
| Total Debt | 9.14 | 8.88 | 12.07 | 9.99 | 12.52 | 1.06 | Upgrade
|
| Net Cash (Debt) | -7.82 | -6.88 | -12.07 | -9.99 | -12.48 | -0.99 | Upgrade
|
| Net Cash Per Share | -0.69 | -0.64 | -0.20 | -0.14 | -0.18 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 12.09 | 12.09 | 10 | 70.5 | 70.5 | 70.5 | Upgrade
|
| Total Common Shares Outstanding | 12.09 | 11.5 | 10 | 70.5 | 70.5 | 70.5 | Upgrade
|
| Working Capital | -7.79 | -7.34 | -12.8 | -10.47 | -12.36 | -0.96 | Upgrade
|
| Book Value Per Share | 0.31 | 0.37 | 2.52 | 0.42 | 0.52 | 0.54 | Upgrade
|
| Tangible Book Value | -14.07 | -13.61 | -18.85 | -15.57 | -9.63 | -9.44 | Upgrade
|
| Tangible Book Value Per Share | -1.16 | -1.18 | -1.89 | -0.22 | -0.14 | -0.13 | Upgrade
|
| Machinery | 0.03 | 0.03 | - | 0.03 | - | - | Upgrade
|
| Construction In Progress | - | - | - | 0.25 | - | - | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.